Skip to main content

Table 2 Factors associated with HBV infection among HAART experienced children at the UoGCSH, 2020

From: Seroprevalence of hepatitis B and C virus among highly active antiretroviral therapy experienced children in Gondar, Ethiopia

Variables

Category

HBV infection

COR (95% CI)

P-value

AOR (95% CI)

P-value

  

Yes N (%)

No N (%)

    

Sex

Female

11(9.2)

109(90.8)

1

   

Male

12(9.9)

109(90.1)

1.09(0.46–2.58)

0.843

  

Age

2–10

4(6.8)

55(93.2)

1

   

11–15

19(10.4)

163(89.6)

1.60(0.52–4.92)

0.409

  

WAZ grouped

Normal

19(8.4)

207(91.6)

1

 

1

 

Under weight

4(26.7)

11(73.3)

3.96(1.15–13.65)

0.029*

3.87(1.04–14.46)

0.044*

BAZ grouped

Normal

19(9.5)

181(90.5)

1

   

Under weight

4(9.8)

37(90.2)

1.03(0.33–3.20)

0.960

  

HAZ grouped

Normal

13(9.6)

122(90.4)

1

   

Stunted

10(9.4)

96(90.6)

0.98(0.41–2.33)

0.960

  

Educational status

Secondary

1(3.3)

29(96.7)

1

   

Primary

21(11)

170(89)

3.58(0.46–27.67)

0.221

  

No formal education

1(5)

19(95)

1.53(0.09–25.90)

0.770

  

Family size

2–4

14(8.1)

158(91.9)

1

   

5–8

9(13)

60(87)

1.69(0.69–4.12)

0.246

  

Family educational status

No formal

7(8.2)

78(91.8)

1

   

Primary

8(10.3)

70(89.7)

1.27(0.44–3.69)

0.656

  

Secondary and above

8(10.3)

70(89.7)

1.27(0.44–3.69)

0.656

  

Marital status of family

Married

11(8.5)

118(91.5)

1

   

Single

3(10)

27(90)

1.19(0.31–4.57)

0.789

  

Widowed

9(11)

73(89)

1.32(0.52–3.35)

0.555

  

WHO HIV stage (at the time of data collection)

I

22(9.5)

210(90.5)

1

   

II

1(11.1)

8(88.9)

1.19(0.14–9.99)

0.871

  

Viral Load rate (at the time of data collection)

Not detected

7(6.2)

105(93.8)

1

 

1

 

 ≤ 1000

7(9.1)

70(90.9)

1.50(0.50–4.46)

0.466

1.52(0.50–4.56)

0.460

 > 1000

9(17.3)

43(82.7)

3.14(1.10–8.97)

0.033

2.80(0.95–8.24)

0.062

  1. *Significantly associated